Posadzy-Małaczyńska A
Kliniki Nadciśnienia Tetniczego, Instytutu Kardiologii Akademii Medycznej w Poznaniu.
Przegl Lek. 1997;54(7-8):524-8.
The aim of the study was to evaluate the effect of angiotensin converting enzyme inhibition on renoscintigraphic curves using DTPA as a tracer in patients with essential (EH) and renovascular (RVH) hypertension. Twenty four patients with EH and sixteen with RVH were studied. Protocol consisted of control renoscintigraphy with DTPA and the second one after captopril administration in dose 25 mg performed after three days. Relative DTPA uptake of the single kidney was calculated from the curve time-activity between 120 and 180 second after tracer administration. Results were expressed as a quotient of the relative DTPA uptake of ischemic or "weaker" kidney to the DTPA uptake of both kidneys (coefficient A) or contralateral one (coefficient B). Coefficient A in basic renoscintigraphy did not differ in patients with EH and RVH and was 45.81 +/- 3.02% and 44.66 +/- 6.17% respectively. In renoscintigraphy with captopril coefficient A decreased significantly (P < 0.001) in patients with RVH and was significantly lower (p < 0.05) than in patients with EH. Change (delta) of coefficient B after captopril was significantly higher in patients with RVH (p < 0.001). Significant correlations were found between delta coefficient A and delta diastolic (DAP) and mean (MAP) arterial pressure as well as delta plasma renin activity (PRA) after captopril in patients with RVH. Similarly, relationships were shown between percentage change (% delta) of coefficient B and % delta of systolic (SAP), DAP and MAP as well as delta PRA after captopril in patients with RVH.
本研究旨在评估血管紧张素转换酶抑制剂对原发性高血压(EH)和肾血管性高血压(RVH)患者使用二乙三胺五乙酸(DTPA)作为示踪剂的肾闪烁造影曲线的影响。研究了24例EH患者和16例RVH患者。方案包括使用DTPA进行对照肾闪烁造影,以及在三天后给予25mg卡托普利后进行第二次造影。根据示踪剂给药后120至180秒之间的曲线时间-活性计算单肾的相对DTPA摄取量。结果以缺血或“较弱”肾的相对DTPA摄取量与双肾(系数A)或对侧肾(系数B)的DTPA摄取量的商表示。基础肾闪烁造影中的系数A在EH和RVH患者中无差异,分别为45.81±3.02%和44.66±6.17%。在卡托普利肾闪烁造影中,RVH患者的系数A显著降低(P<0.001),且显著低于EH患者(P<0.05)。卡托普利后系数B的变化(δ)在RVH患者中显著更高(P<0.001)。在RVH患者中,发现卡托普利后系数A的变化δ与舒张期(DAP)和平均(MAP)动脉压变化δ以及血浆肾素活性(PRA)变化δ之间存在显著相关性。同样,在RVH患者中,显示了卡托普利后系数B的百分比变化(%δ)与收缩期(SAP)、DAP和MAP的%δ以及PRA变化δ之间的关系。